Loading...

Ayala Pharmaceuticals, Inc.

AYLANASDAQ
Healthcare
Biotechnology
$0.53
$0.00(0.00%)

Ayala Pharmaceuticals, Inc. AYLA Peers

See (AYLA) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AYLA$0.53+0.00%0N/AN/AN/A
VRTX$441.30-0.47%113.3B-114.92-$3.84N/A
REGN$521.00+0.00%55.3B13.24$39.35+0.17%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$322.83+1.44%42.1B-153.00-$2.11N/A
ARGX$560.14+0.02%34.2B34.18$16.39N/A
BNTX$106.72+0.55%25.7B-29.16-$3.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$35.87+1.70%20.2B14.64$2.45+2.42%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

AYLA vs VRTX Comparison

AYLA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AYLA stands at 0. In comparison, VRTX has a market cap of 113.3B. Regarding current trading prices, AYLA is priced at $0.53, while VRTX trades at $441.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AYLA currently has a P/E ratio of N/A, whereas VRTX's P/E ratio is -114.92. In terms of profitability, AYLA's ROE is -2.30%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, AYLA is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for AYLA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;